Prospective and Retrospective Study of Outcomes for Patients with Malignant Melanoma
Study Description
Advances in the treatment of malignant melanoma are being developed in terms of medical information on
diagnosis, surgery, adjuvant therapy and post-treatment surveillance. The purpose of this protocol would be to
create a data repository by collecting key data elements to watch for patterns within melanoma to potentially
help future patients. By collecting this data, we intend to assess trends by watching for patterns of melanoma
inclusive of treatment, criteria for staging, time to recurrence, population, patients at risk for recurrence,
survival of patients, and time to death. The collection of this data will include a retrospective collection of
historical patients and a prospective collection from new patients within the melanoma UC Irvine Health clinics
Eligibility
You are eligible to participate in this study if you are at least 18 years old and have a confirmed diagnosis of
melanoma.
Interested in Participating in this Trial?
Thank you for your interest with our team.
One of our specialists will be in contact with you soon.